Bio-Rad Laboratories Inc (BIO)
Profitability ratios
Return on sales
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | |
|---|---|---|---|---|---|
| Gross profit margin | 53.73% | 53.42% | 55.93% | 56.14% | 56.48% |
| Operating profit margin | 10.48% | 12.65% | 17.22% | 16.75% | 16.14% |
| Pretax margin | -91.27% | -31.82% | -167.87% | 186.08% | 192.79% |
| Net profit margin | -71.86% | -23.86% | -129.45% | 145.57% | 149.83% |
Based on the provided data, we can analyze the profitability ratios of Bio-Rad Laboratories Inc over the past five years:
1. Gross Profit Margin:
- The gross profit margin decreased slightly from 56.48% in 2020 to 53.73% in 2024. This indicates a decreasing trend in the percentage of revenue retained after accounting for the cost of goods sold.
2. Operating Profit Margin:
- The operating profit margin fluctuated over the period, with a peak of 17.22% in 2022 and a low of 10.48% in 2024. Despite the fluctuations, the company maintained a relatively stable operating profit margin.
3. Pretax Margin:
- The pretax margin showed significant variability, ranging from 192.79% in 2020 to -167.87% in 2022. The negative pretax margins in 2022, 2023, and 2024 suggest that the company's expenses and other costs exceeded its earnings before taxes in those years.
4. Net Profit Margin:
- The net profit margin also exhibited fluctuations, with a high of 149.83% in 2020 and a low of -71.86% in 2024. The negative net profit margins in 2022, 2023, and 2024 indicate that the company experienced net losses in those years after accounting for all expenses and taxes.
Overall, Bio-Rad Laboratories Inc's profitability ratios reflect a mix of performance trends, with some margins declining or fluctuating over the years. It is recommended that the company closely monitors its cost management and revenue generation strategies to improve profitability in the future.
Return on investment
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | |
|---|---|---|---|---|---|
| Operating return on assets (Operating ROA) | 2.87% | 2.75% | 3.57% | 2.75% | 3.17% |
| Return on assets (ROA) | -19.69% | -5.18% | -26.87% | 23.93% | 29.40% |
| Return on total capital | -34.91% | -8.63% | -48.53% | 39.88% | 49.89% |
| Return on equity (ROE) | -28.07% | -7.29% | -37.73% | 31.13% | 38.61% |
Bio-Rad Laboratories Inc's profitability ratios demonstrate varying trends over the years.
- Operating ROA has shown some fluctuation with a slight increase from 3.17% in 2020 to 3.57% in 2022, before dropping back to 2.75% in 2024.
- ROA exhibited a significant decrease in 2021 compared to 2020, followed by negative values in subsequent years, indicating a decline in the company's ability to generate profit from its assets.
- Return on total capital displayed a downward trend from 2020 to 2024, with the ratio turning negative in 2022 and remaining so in the following years, suggesting a decrease in the company's ability to generate returns from its total invested capital.
- ROE followed a similar pattern as ROA and return on total capital, showing a decrease in profitability over the years, with negative values indicating a negative impact on shareholders' equity.
Overall, the declining profitability ratios highlight challenges faced by Bio-Rad Laboratories Inc in generating returns for both its assets and capital, as well as delivering value to its shareholders.